World News: 01:13 GMT Friday 7th December 2018. [Momenta Pharmaceuticals, Inc. via Globe Newswire via SPi World News]
CAMBRIDGE Mass Dec 06 2018 GLOBE NEWSWIRE -- Momenta Pharmaceuticals Inc Nasdaq MNTA a biotechnology company with a validated scientific platform focused on discovering and developing novel therapeutics to treat rare immune-mediated disease...
Globe Newswire: 01:13 GMT Friday 7th December 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.